Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
about
Interventions for self-harm in children and adolescentsParacetamol for low back painLiver transplant associated with paracetamol overdose: results from the seven-country SALT studyEffects of single-dose injectable paracetamolversus propacetamol in pain management after minor gynecologic surgery: A multicenter, randomized, double-blind, active-controlled, two-parallel-group study.Measuring the population burden of injuries--implications for global and national estimates: a multi-centre prospective UK longitudinal studyParacetamol use (and/or misuse) in children in Enugu, South-East, Nigeria.A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjectsUnderstanding lactic acidosis in paracetamol (acetaminophen) poisoning.Using the simulated patient methodology to assess paracetamol-related counselling for headache.Management of acute paracetamol poisoning in a tertiary care hospital.The protective effects of aqueous extract of Carica papaya seeds in paracetamol induced nephrotoxicity in male wistar rats.Minimising the potential for metabolic activation in drug discovery.Where to buy OTC medications? A cross-sectional survey investigating consumers' confidence in over-the-counter (OTC) skills and their attitudes towards the availability of OTC painkillersQuantitative analysis of the scientific literature on acetaminophen in medicine and biology: a 2003-2005 study.Paracetamol in the environment and its degradation by microorganisms.Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents.Trends in rates of acetaminophen-related adverse events in the United States.The β-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers through increasing progenitor numbers by Wnt in mice.Analgesic efficacy of parenteral paracetamol (propacetamol) and diclofenac in post-operative orthopaedic pain.Prophylactic measures.Cost minimization analysis comparing enteral N-acetylcysteine to intravenous acetylcysteine in the management of acute acetaminophen toxicity.New recommendation for N-acetylcystiene dosing may reduce incidence of adverse effects.Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States.Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro.Acute poisonings treated in hospitals in Oslo: a one-year prospective study (II): clinical outcome.Analysis of an 8-hour acetylcysteine infusion protocol for repeated supratherapeutic ingestion (RSTI) of paracetamol.Electron attachment to antipyretics: Possible implications of their metabolic pathways
P2860
Q24187033-0F77C34D-E990-43C7-BE54-1161FA815FF7Q26278817-F699CB84-80A0-4A15-8A9A-785A07F6768DQ28607494-945CBF7D-263B-478B-9D5C-4665F09FE259Q33737649-44F6A2A2-0524-48B3-B927-89A5883F718CQ34097768-C250798F-C1C8-478C-9DA3-95B30BEFB47EQ34343678-DE66454D-AE8B-4EFA-87B0-D9C5A1A6E1DCQ34474876-A1B0A66E-8F59-4340-8D50-DF06D3933805Q34476057-F2793894-FD11-4686-964E-B661F549817CQ34540797-36C16498-2A51-4046-A5A9-B8D8C270218EQ35132346-F8A37DC2-B441-4610-9E63-57604C15D72AQ35780675-4578AA13-0C43-4191-82DB-C9BD17488207Q36572637-CF017032-CA13-48E7-B55F-C4AEE5859E90Q37208421-6A0CD3DD-C36D-47FF-80A8-6788932EE912Q37418099-8E3C34D8-514A-4954-8293-1502CB07CABAQ38050994-6073E3AA-6BD5-4D2F-A594-F69D4F8B86B1Q38644861-AD8906ED-02B5-4FCE-950F-99DEAC13897FQ38946697-490E7CA5-A9EB-44D7-9B74-89D762E01143Q38985481-575E52B0-CCE6-4507-94EA-87949CFC3F8AQ39354932-391ACD2D-4AB4-4F3A-95AF-8224DBA85F87Q41845864-5BD37C6E-153C-44FE-A54E-8E396C11E2BBQ43185909-B1C12B9D-BD1A-4251-A2BD-05CBEBCB4092Q43245812-EF8F5958-A008-4C1A-A81D-DF9369D071CDQ44492403-AE73DF81-0AF2-4C3B-AAD3-EB70DD57D994Q46327411-A676CB90-1DD2-4FBB-A4BD-7B391288E693Q46827064-C1E99C7E-34C7-4499-9785-BE4EC6B055B9Q50502593-7D27A6FA-5CE2-4AA2-8662-C330D0AA9230Q57520062-6698776F-2941-4FC0-97A6-151654074541
P2860
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
@ast
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
@en
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
@nl
type
label
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
@ast
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
@en
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
@nl
prefLabel
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
@ast
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
@en
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.
@nl
P2093
P356
P1476
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system
@en
P2093
D N Bateman
J F Dillon
K J Simpson
P304
P356
10.1093/QJMED/95.9.609
P407
P577
2002-09-01T00:00:00Z